CORT
Corcept Therapeutics Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Corcept Therapeutics Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Corcept Therapeutics has 6 disclosed suppliers and 1 disclosed customer in SEC filings.
SentenceIn collaboration with the Paris-based academic research cooperative ARCAGY-GINECO, we will initiate, in the first quarter of 2026, a Phase 2 trial, STELLA, in 50 patients with cervical cancer, who have received one or two prior lines of therapy.
CORT 10-Kaccession 0001628280-26-011091
SentenceOur new specialty pharmacy vendor, Curant, dispenses our Products and performs related pharmacy and patient support services, including the collection of payments from insurers representing more than 99 percent of our revenue.
CORT 10-Kaccession 0001628280-26-011091
SentenceMedpace Research is helping us conduct our MOMENTUM and MONARCH trials.
CORT 10-Kaccession 0001628280-26-011091
SentenceFrom 2017 until 2025, we used an exclusive specialty pharmacy vendor, Optime and a specialty distributor to distribute our Products and provide logistical support to physicians and patients.
CORT 10-Kaccession 0001628280-26-011091
SentenceSyneos Health is helping us conduct our ROSELLA and BELLA trials.
CORT 10-Kaccession 0001628280-26-011091
SentencePatents we have licensed from the University of Chicago cover the use of relacorilant combined with anticancer agents, including enzalutamide, to treat patients with this disease.
CORT 10-Kaccession 0001628280-26-011091
SentenceFrom 2017 until 2025, we used an exclusive specialty pharmacy vendor, Optime Care, Inc. ("Optime") and a specialty distributor to distribute our Products and provide logistical support to physicians and patients.
CORT 10-Kaccession 0001628280-26-011091
Corcept Therapeutics Inc
81.20
Largest filed tie
—
Expected move
Inputsspot 81.12exp Nov 20ATM strike 80ATM straddle 12.15IV 79%